PQA

SEPTEMBER 8, 2023

Building Consensus to Improve Oncology Quality Measurement Recommendations to Improve the Quality of Oral Anticancer Medication Use is a new report that shares the consensus-based recommendations of 23 national experts and patients, who were convened by PQA, to prioritize opportunities for improving the quality of OAM use. Register today!

Community Pharmacies 52

Community Pharmacies 52

PQA

APRIL 21, 2023

We also highlight our members' perspectives on specialty medication adherence, technology and expanding oncology pharmacists' role. Expanding Roles of Oncology PharmacistsCommunity Oncology Alliance's Judith Alberto joined a panel to discuss oncology pharmacists' expanding roles in traditional and nontraditional career paths.

Specialty Pharmacies 40

Specialty Pharmacies Communication 40

pharmaphorum

SEPTEMBER 28, 2020

pharmaphorum’s Behavioural insights into haem/onc clinical decision making webinar, in association with Medscape, showed that this can negatively impact physicians’ confidence as they try and keep on top of information about an array of treatment options. Data from the US cited during the webinar showed a five-year survival rate of 34.2%

FDA 105

FDA Hospitals 105

PQA

OCTOBER 21, 2022

Our initial goal is to forge national consensus among oncology and quality experts on the most meaningful measurement concepts and the solutions needed for improving medication use and medication management services. November's PQA Quality Forum Webinar, featuring PQS, will provide insights on the ratings. PQS' Andrew Thorne.

40

40

PQA

DECEMBER 27, 2023

Building Consensus on Priorities for Improving Oncology Quality Measurement (August 29) PQA released an important report that we believe is a key step towards improving the quality of care for individuals using oral anticancer medications (OAM). As we close out 2023, here’s a look back at the top five blogs of the year.

52

52

pharmaphorum

OCTOBER 30, 2019

Overview Oncology treatment increasingly involves combinations of novel oral and biologic drugs. Traditional utilization management tools are still difficult to apply in oncology, given no payer wants to be on the front page of a major newspaper for denying treatment. Pathways have not held up to their promise for containing cost.

Chemotherapy 40

Chemotherapy 40

pharmaphorum

JUNE 27, 2016

The ASCO Annual Meeting, the largest global oncology meeting and increasingly the centre of a kaleidoscope of social media coverage each year. This webinar will examine the conversation around ASCO 2016, its relationship with ASCO, value to and involvement from stakeholder groups and how it will potentially continue to evolve into 2017.

52

52

PQA

FEBRUARY 24, 2023

Additionally, these results help validate methodology for discontinuations, especially as organizations such as PQA continue their initiatives to create standard quality measures in oncology. The next PQA Quality Essentials Webinar is Thursday, March 16, 1-2 pm ET. A registration link is available in the Member Resources Library.

Labelling 52

Labelling Medication Labelling Hospitals 52

pharmaphorum

FEBRUARY 11, 2016

The first in a trilogy of webinars focussed on the topic; Unlocking the value; the economic equation and part of the IMS Health Practical Insights series. Answering this paradigm is where real world evidence can step in.

52

52

PQA

DECEMBER 16, 2022

Driving Forward on Pharmacy and Oncology Measures PQA is developing a set of standard pharmacy performance measures suitable for assessing pharmacy performance and for use in value-based arrangements (VBAs). The next PQA Quality Forum Webinar, is Thursday, January 19, 1-2 pm ET.

Hospitals 40

Hospitals FDA 40

pharmaphorum

DECEMBER 21, 2021

In a recent webinar held by pharmaphorum, in partnership with IQVIA, a discussion was held looking at how to make academic and commercial medical research more efficient, while also looking at the opportunity of genomic data to bring benefits to patients and healthcare systems.

Pharmaceutical Companies 98

Pharmaceutical Companies Pharmaceutical Companies Hospitals FDA 98

Roots Analysis

FEBRUARY 14, 2023

Further, the most targeted disease area within oncological disorders is ovarian cancer, with 226 clinical trials registered in the given time period. Broad Clinical Trial Landscape Till date, close to 800 clinical studies evaluating various liposome-based therapeutics have been initiated worldwide.

52

52

Pharma Marketing Network

FEBRUARY 4, 2021

Oncology Digital Marketing & Customer Experience at GSK. Watch the full webinar here to get in-depth responses from this great group of panelists. The post Webinar Recap – Video, Voice, and Virtual: Applying New Digital Technology to Enhance Customer Experience with PMN appeared first on Pharma Marketing Network.

98

98

pharmaphorum

MARCH 10, 2017

We also see member states working to understand the process of enabling cost-effective patient access to personalised and high-cost treatments, such as new oncology combination therapies, antibiotics and stem cell therapies, which offer the promise of efficacy in key disease areas.

52

52

pharmaphorum

JANUARY 26, 2023

“Any focus on improving patient access to innovative medicines – especially for rare and ultra-rare diseases – is extremely welcome,” said Sean Richardson, VP and general manager UK & Ireland, Alexion during a recent pharmaphorum webinar. That showed that collaboration can deliver,” McFarlane concluded.

58

58

pharmaphorum

MARCH 21, 2022

In this webinar, we will discuss the challenges CEOs face and their personal journey during this exciting stage of entrepreneurship. This webinar will cover: Key success factors. Panel discussions will be based around the recent publication The Digital Health Start-up Journey: From Series A to scaling up. Post-Series A challenges.

Hospitals 145

Hospitals Pharmaceutical Companies Pharmaceutical Companies 145

pharmaphorum

JANUARY 27, 2021

Information from the ‘cradle to grave’ care it provides has tremendous potential for driving more research within the UK, notably in oncology, with patients, regulators, payers, researchers, clinicians and the NHS itself all likely to benefit. In the current environment, it can also measure the impact of COVID-19 on oncology pathways.

Patient Care 143

Patient Care Hospitals Chemotherapy Vaccines 143

pharmaphorum

SEPTEMBER 30, 2021

We are also highlighting the enduring importance of research, which has not only impacted the treatment of blood cancer but has triggered insights across oncology. Help and support for blood cancer patients. This month we’ve also launched a range of material for people who’ve been newly diagnosed.

Vaccines 52

Vaccines Communication 52

pharmaphorum

OCTOBER 7, 2021

However, developments in genomic medicine are making huge strides to improve this situation, and these will also be discussed during the webinar. He also serves as haematology consultant to the NICU and genetics service and is co-director of the NIH/Johns Hopkins Pediatric Hematology/Oncology Fellowship Program.

Hospitals 98

Hospitals 98

pharmaphorum

MAY 18, 2022

This was the focus of a recent pharmaphorum webinar , held in association with the National Institute of Health and Care Research (NIHR) where experts from the NIHR and Roche discussed the potential of healthcare data in commercial clinical research. Ed Merivale is therapy relationship manager, oncology at Roche.

Hospitals 80

Hospitals 80

The FDA Law Blog

DECEMBER 11, 2023

During the October 31, 2023 webinar discussing the proposed rule, stakeholders sought clarity from FDA officials on the Agency’s plan to address the resource gap. FDA, Transcript of CDRH Webinar regarding Proposed Rule: Medical Devices; Laboratory Developed Tests, at 9-10 (Oct. 31, 2023), [link]. [10] 11] Jeffrey N. Gibbs, Allyson B.

FDA 69

FDA Research Laboratories Documentation 69

Pharma Marketing Network

NOVEMBER 19, 2020

In this webinar, the Association of Medical Media (AMM) gave industry leaders a chance to share how their organizations are responding to the challenges of the unique environment we are currently living in. Lori and Jim stayed on to answer viewers’ questions after the webinar completed its agenda.

Communication 98

Communication 98

Pharmaceutical Technology

FEBRUARY 13, 2023

Candidate selection case study: Progression of small molecule ‘developability’ Background: A US biotech company had identified nine structurally related compounds as potential candidates in an oncology discovery program. Quotient Sciences was asked to select the best candidate based on material science and oral bioavailability considerations.

Compounding 52

Compounding Dosage 52

Pharmaceutical Technology

MARCH 17, 2023

Over the last twenty years, there has been a major rise in risk sharing agreements in the pharmaceutical space, said Alex Watt, GlobalData’s principal research analyst, at a recent webinar on the same topic. Between 2012 and 2022, the number of oncology risk sharing agreements increased massively by 498%.

Pharmaceutical Companies 102

Pharmaceutical Companies Pharmaceutical Companies Communication 102

Pharmaceutical Technology

MAY 23, 2023

Oncology was the main therapy area, accounting for 218 trials, followed by central nervous system drugs having 185, and infectious diseases next with 138. Oncology remains the highest indication area with eight trials, with ophthalmology next at six. To learn more about the clinical trial services in Ukraine, access the webinar below.

Communication 52

Communication 52